Survival Rate for Advanced-stage Prostate Cancer Patients with Surgery
Topic: Prostate Cancer
Author: Mayo Clinic
Published: 2011/05/15 - Updated: 2023/11/09
Publication Type: Informative - Peer-Reviewed: Yes
Contents: Summary - Introduction - Main - Related
Synopsis: Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery. Previously, patients found to have cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy. The 80 percent survival rate for cT3 diagnoses at 20 years compares to 90 percent for cT2, or cancer confined to the prostate.
Introduction
Advanced-stage prostate cancer patients experience 20-year survival rates with surgery. Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found.
Main Digest
Their study found a 20-year survival rate for 80 percent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland. Previously, patients found to have cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy.
The researchers presented their findings during the American Urological Association Annual Meeting in Washington.
"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," says R. Jeffrey Karnes, M.D., of Mayo Clinic's Department of Urology. "We have confirmed that patients diagnosed with locally advanced prostate cancer can enjoy a long, cancer-free interval."
The 80 percent survival rate for cT3 diagnoses at 20 years compares to 90 percent for cT2, or cancer confined to the prostate.
This long-term follow-up of patients who underwent surgery between 1987 and 1997 is an important advance in understanding the quality outcomes for cT3 patients.
The study sample included patients diagnosed and operated on between 1987 and 1997. Ongoing research will examine contemporary data.
Other study investigators include Christopher Mitchell, M.D., Eric Umbreit, M.D., Rachel Carlson and Laureano Rangel, all of Mayo Clinic.
Attribution/Source(s):
This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by Mayo Clinic, and published on 2011/05/15 (Edit Update: 2023/11/09), the content may have been edited for style, clarity, or brevity. For further details or clarifications, Mayo Clinic can be contacted at mayoclinic.org. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Mayo Clinic. (2011, May 15 - Last revised: 2023, November 9). Survival Rate for Advanced-stage Prostate Cancer Patients with Surgery. Disabled World. Retrieved September 15, 2024 from www.disabled-world.com/health/cancer/prostate/advanced-stage.php
Permalink: <a href="https://www.disabled-world.com/health/cancer/prostate/advanced-stage.php">Survival Rate for Advanced-stage Prostate Cancer Patients with Surgery</a>: Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.